The aggressiveness of MTC in patients with MEN2 correlates with the pheochromocytoma penetrance and the severity of the autosomal dominant (AD) pathogenic RET proto-oncogene variants [41]. This evidence concerns the gene RET and hereditary pheochromocytoma-paraganglioma.